DTL promotes head and neck squamous cell carcinoma progression by mediating the degradation of ARGLU1 to regulate the Notch signaling pathway

• Published in: International journal of biological macromolecules 2024-02, Vol.259 (Pt 2), p.129184-129184, Article 129184
• Main Authors: Shi, Jingpei, Yu, Xiaonan, Li, Guoyu, Zhao, Xiaoyu, Chen, Jiwen, Fang, Ying, Yang, Yan, Wang, Ting, Xu, Tianyong, Bian, Li, Lyu, Lechun, He, Yongwen
• Format: Article
• Language: English
• Subjects: ARGLU1; DTL; head and neck squamous cell carcinoma; Notch signaling pathway
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2023.129184

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with a high incidence in squamous epithelium. The E3 ubiquitin ligase DTL is a component of the CRL4A complex and is widely involved in tumor progression. We aimed to analyze the role of DTL in HNSCC and to explore its mechanism of action. Through clinical analysis, we found that DTL is upregulated in HNSCC tissues and is associated with the tumor microenvironment and poor survival in patients. Through gain-of-function and loss-of-function assays, we showed that DTL promotes cell proliferation and migration in vitro and tumor growth in vivo. Mass spectrometry analysis and immunoprecipitation assays showed that DTL interacts with ARGLU1 to promote K11-linked ubiquitination-mediated degradation of ARGLU1, thereby promoting the activation of the CSL-dependent Notch signaling pathway. Furthermore, siARGLU1 blocks the inhibitory effects of DTL knockdown on HNSCC cells. In this study, we showed that DTL promotes HNSCC progression through K11-linked ubiquitination of ARGLU1 to activate the CSL-dependent Notch pathway. These findings identify a promising therapeutic target for HNSCC.